Nabi Biopharmaceuticals
Rockville
About Nabi Biopharmaceuticals
Nabi develops preventive measures and treatements. Nabi Biopharmaceuticals develops preventive measures and treatments for diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 1 – 10
- Total funding: $10.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Sep 2009)
- Ticker: nasdaq:NABI
- Website: nabi.com
- Phone: +855 2756224
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nabi-biopharmaceuticals-1983939 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.